ZEVRA THERAPEUTICS, INC. (ZVRA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US4884452065
ZEVRA THERAPEUTICS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 106.47 m USD |
| Gross profit | 89.99 m USD |
| Operating income | -62.94 m USD |
| EBIT | 94.66 m USD |
| Net income | 83.23 m USD |
| Diluted EPS – continuing operations | 1.35 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ZEVRA THERAPEUTICS, INC.
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 3 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 3 clinical trial to treat narcolepsy. The company is developing Celiprolol, an investigational product candidate that is under Phase 3 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit and hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and MIPLYFFA for the treatment of niemann-pick disease type C, an ultra-rare neurodegenerative disease. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. The company was incorporated in 2006 and is headquartered in Boston, Massachusetts.
More stocks
- Granite Ridge Resources, Inc. (GRNT)
- Endur ASA (ENDUR.OL)
- Lithium Argentina AG (LAR)
- Yixin Group Ltd (2858.HK)
- Jiangxi Bestoo Energy Co Ltd (001376.SZ)
- Osisko Metals Inc (OM.TO)
- Acrel Co LTD (300286.SZ)
- Vats Liquor Chain Store Management Joint Stock Co Ltd (300755.SZ)
- Xingtong Shipping Co. Ltd. (603209.SS)
- Qingdao Eastsoft Communic Tech (300183.SZ)
- Sanken Electric Co Ltd (6707.T)
- Wuhan Xianglong Power Industry Co Ltd (600769.SS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.